Cancer Genetics, Inc. CGIX
No live quote for CGIX yet.
Valuation
P/E -0.9×
FY 2020 5y median -0.9× FY 2020
P/S 0.0×
FY 2020 5y median 0.0× FY 2020
P/B 0.0×
FY 2020 5y median 0.0× FY 2020
P/FCF 0.0×
FY 2020 5y median 0.0× FY 2020
EV/EBITDA 0.3×
FY 2020 5y median 0.3× FY 2020
EV/Sales -0.4×
FY 2020 5y median -0.4× FY 2020
FCF Yield 0.0%
FY 2020 5y median 0.0% FY 2020
Profitability
Gross Margin 41.7%
FY 2020 5y median 41.7% FY 2020
Operating Margin -142.3%
FY 2020 5y median -142.3% FY 2020
Net Margin -139.1%
FY 2020 5y median -139.1% FY 2020
ROE -201.0%
FY 2020 5y median -201.0% FY 2020
ROIC -234.3%
FY 2020 5y median -234.3% FY 2020
ROA -106.2%
FY 2020 5y median -106.2% FY 2020
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2020
Operating Income 0.0%
FY 2020 FY 2020
EPS (diluted) 0.0%
FY 2020 FY 2020
Free Cash Flow 0.0%
FY 2020 FY 2020
Financial Health
Current Ratio 1.0×
FY 2020 5y median 1.0× FY 2020
Quick Ratio 1.0×
FY 2020 5y median 1.0× FY 2020
Debt / Equity 0.1×
FY 2020 5y median 0.1× FY 2020
Net Debt / EBITDA 0.3×
FY 2020 5y median 0.3× FY 2020
Interest Coverage -30.1×
FY 2020 5y median -30.1× FY 2020
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2020
Annual · latest fiscal year ends 2020-12-31